Teva, AbbVie ink opioid settlements worth nearly $330M with Florida

Teva has been busy lately striking deals with U.S. states to resolve opioid claims. Now, the generics giant and another major pharma company—AbbVie—are ponying up to settle cases in Florida.

The Israel-based drugmaker and AbbVie's Allergan unit agreed to pay around $329 million to resolve the state's opioid litigation, Florida Attorney General Ashley Moody said Wednesday.